関連する実験動画
Updated: Jan 7, 2026

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA
Published on: April 30, 2020
ナイジェリアの2つの矯正施設における症状に基づく活動性結核スクリーニング:横断研究
Victor Abiola Adepoju1, Olusola Daniel Sokoya2, Safayet Jamil3,4
1Department of HIV and Infectious Diseases, Jhpiego Nigeria (affiliate of Johns Hopkins University), Federal Capital Territory, Abuja, Nigeria.
ナイジェリアの刑務所におけるGeneXpert検査を用いた活動性結核症の発見は、結核(TB)の検出率を大幅に向上させた。この体系的なアプローチは、受動的方法よりも多くの結核症例を特定し、矯正施設における公衆衛生の重要性を強調している。
科学分野:
- Public Health
- Infectious Disease Epidemiology
- Clinical Diagnostics
背景:
- Tuberculosis (TB) poses a significant health threat in Nigerian correctional facilities, with prevalence rates up to ten times higher than the general population.
- Traditional passive TB case detection methods often fail to identify asymptomatic infections, necessitating improved screening strategies.
研究 の 目的:
- To evaluate a systematic active case-finding (ACF) strategy employing symptom-based screening and GeneXpert MTB/RIF testing in two Nigerian correctional facilities.
- To determine the effectiveness of ACF in enhancing TB diagnosis within a high-prevalence correctional setting.
主な方法:
- A total of 2,244 inmates were screened for TB symptoms between April and September 2021.
- Presumptive TB cases provided sputum for GeneXpert analysis, with interventions including outreach screening, cell-to-cell searches, and contact tracing.
- Data were analyzed to calculate detection rates per 100,000 inmates and overall positivity yield.
主要な成果:
- The study identified 45 confirmed TB cases, yielding an estimated prevalence of 0.5% (489 per 100,000 inmates), more than double the national average.
- The overall TB positivity rate among presumptive inmates was 7%, with point prevalence in Lagos and Ogun states at 500 and 458 per 100,000, respectively.
- All detected TB cases were rifampicin-sensitive, with no drug-resistant strains identified.
結論:
- Symptom-based GeneXpert screening is an effective method for active case-finding in correctional facilities, substantially improving upon passive detection rates.
- Systematic ACF, including universal entry screening and regular facility-wide checks, is crucial for early TB diagnosis and treatment initiation in high-risk environments.
- Recommendations include institutionalizing routine ACF, integrating rapid molecular testing, and considering digital radiography for enhanced TB control in correctional settings.
さらに関連する動画
09:57System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
Published on: April 5, 2017
09:54Synthesis, Characterization, and Application of Superparamagnetic Iron Oxide Nanoprobes for Extrapulmonary Tuberculosis Detection
Published on: February 16, 2020
関連する概念動画
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories: